Papamarkou Wellner Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Hold
3,166
1.83% 18
2026
Q1
$2.91M Buy
3,166
+135
+4% +$137K 1.78% 19
2025
Q4
$3.26M Sell
3,031
-3
-0.1% -$2.87K 1.96% 15
2025
Q3
$2.31M Hold
3,034
1.43% 22
2025
Q2
$2.37M Buy
3,034
+138
+5% +$107K 1.57% 17
2025
Q1
$2.39M Buy
2,896
+57
+2% +$47.4K 1.67% 16
2024
Q4
$2.19M Buy
+2,839
New +$2.35M 1.51% 21

Other funds holding LLY

Papamarkou Wellner Asset Management's LLY Position: Q2 2026 in Review

Papamarkou Wellner Asset Management held its Eli Lilly (LLY) position steady in Q2 2026 at 3,166 shares worth $2.91M. The position accounts for 1.83% of the portfolio, ranked #18.

Papamarkou Wellner Asset Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.26M in Q4 2025. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Papamarkou Wellner Asset Management held 3,166 shares of Eli Lilly worth $2.91M as of Q2 2026.
  • Papamarkou Wellner Asset Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 1.83% of Papamarkou Wellner Asset Management's portfolio in Q2 2026, its #18 holding.
  • Papamarkou Wellner Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Papamarkou Wellner Asset Management's Eli Lilly position peaked at $3.26M in Q4 2025.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Papamarkou Wellner Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.